Merck KGaA

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra Other stock markets 11:35:01 2024-12-13 EST			5-day change	1st Jan Change
141.15 ^EUR	-1.40%		+1.00%	-2.05%

12-13	After years of crisis: Chemicals industry expects mini-growth in 2025	DP
12-11	MERCK KGAA : JP Morgan keeps its Buy rating	ZD

MERCK KGAA : Gets a Buy rating from Jefferies

July 18, 2024 at 08:53 am

Jefferies is positive on the stock with a Buy rating. Previously set at EUR 200, the target price is lowered to EUR 180.

Latest news about Merck KGaA

After years of crisis: Chemicals industry expects mini-growth in 2025	12-13	DP
MERCK KGAA : JP Morgan keeps its Buy rating	12-11	ZD
MERCK KGAA : Receives a Buy rating from JP Morgan	12-03	ZD
MERCK KGAA : Receives a Buy rating from DZ Bank	12-02	ZD
Reckitt Benckiser adds Bacardi CEO and ex-Merck CEO to board	11-27	AN
Reckitt Benckiser Group plc Announces Directorate and committee Appointments	11-27	CI
Moody's Affirms Merck KGaA's Ratings, Outlook on Solid Operational Diversification	11-21	MT
AlphaValue/Baader Europe Upgrades Merck KGaA to Buy, Lifts PT	11-20	MT
Trump-induced Pharma fears shouldn't be long-lived	11-19
MERCK KGAA : JP Morgan keeps its Buy rating	11-18	ZD
MERCK KGAA : Deutsche Bank gives a Buy rating	11-15	ZD
MERCK KGAA : Buy rating from UBS	11-15	ZD
MERCK KGAA : Goldman Sachs maintains a Buy rating	11-15	ZD
MERCK : A strong Q3 requires some upward revision for 2024	11-15
Health Care Down Amid RFK Fears -- Health Care Roundup	11-14	DJ
Germany's DAX Index Jumps on Siemens' Profit Beat	11-14	MT
MERCK : The expected modification	11-14
Global markets live: Walt Disney, Cisco, ASML, Burberry, Aviva...	11-14
Merck KGaA, Q3 2024 Earnings Call, Nov 14, 2024	11-14
Merck's result rises more strongly than expected	11-14	RE
Jefferies rates Merck KGaA at 'Buy' - Target 180 euros	11-14	DP
MERCK KGAA : Gets a Buy rating from Goldman Sachs	11-14	ZD
MERCK KGAA : JP Morgan maintains a Buy rating	11-14	ZD
MERCK KGAA : UBS reiterates its Buy rating	11-14	ZD
MERCK KGAA : Jefferies keeps its Buy rating	11-14	ZD

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).

Employees

62,255

Sector

Pharmaceuticals

Calendar

2025-03-05 - Q4 2024 Earnings Call

More about the company